These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 33961833)

  • 1. Risk prediction of drug-drug interaction potential of phenytoin and miconazole topical formulations.
    Li W; Wang Z; Wang X; Cao X; Bi C; Jiang L; Cui S; Liu Y
    Chem Biol Interact; 2021 Jul; 343():109498. PubMed ID: 33961833
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of phenytoin hydroxylation in human liver microsomes by several selective serotonin re-uptake inhibitors.
    Nelson MH; Birnbaum AK; Remmel RP
    Epilepsy Res; 2001 Apr; 44(1):71-82. PubMed ID: 11255075
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HLM chip - A microfluidic approach to study the mechanistic basis of cytochrome P450 inhibition using immobilized human liver microsomes.
    Pihlaja T; Kiiski I; Sikanen T
    Eur J Pharm Sci; 2024 Jun; 197():106773. PubMed ID: 38641124
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The "albumin effect" and in vitro-in vivo extrapolation: sequestration of long-chain unsaturated fatty acids enhances phenytoin hydroxylation by human liver microsomal and recombinant cytochrome P450 2C9.
    Rowland A; Elliot DJ; Knights KM; Mackenzie PI; Miners JO
    Drug Metab Dispos; 2008 May; 36(5):870-7. PubMed ID: 18256202
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Potential herb-drug interaction risk of thymoquinone and phenytoin.
    Wang Z; Wang X; Wang Z; Lv X; Yin H; Li W; Li W; Jiang L; Liu Y
    Chem Biol Interact; 2022 Feb; 353():109801. PubMed ID: 34998822
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibitory effects of curcumin on activity of cytochrome P450 2C9 enzyme in human and 2C11 in rat liver microsomes.
    Wang Z; Sun W; Huang CK; Wang L; Xia MM; Cui X; Hu GX; Wang ZS
    Drug Dev Ind Pharm; 2015 Apr; 41(4):613-6. PubMed ID: 24517573
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Human CYP2C-mediated stereoselective phenytoin hydroxylation in Japanese: difference in chiral preference of CYP2C9 and CYP2C19.
    Yasumori T; Chen LS; Li QH; Ueda M; Tsuzuki T; Goldstein JA; Kato R; Yamazoe Y
    Biochem Pharmacol; 1999 Jun; 57(11):1297-303. PubMed ID: 10230773
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Drug-drug interaction of antifungal drugs].
    Niwa T; Shiraga T; Takagi A
    Yakugaku Zasshi; 2005 Oct; 125(10):795-805. PubMed ID: 16205037
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of antifungal drugs on cytochrome P450 (CYP) 2C9, CYP2C19, and CYP3A4 activities in human liver microsomes.
    Niwa T; Shiraga T; Takagi A
    Biol Pharm Bull; 2005 Sep; 28(9):1805-8. PubMed ID: 16141567
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cytochrome P450 2C9-natural antiarthritic interactions: Evaluation of inhibition magnitude and prediction from in vitro data.
    Tan BH; Ahemad N; Pan Y; Palanisamy UD; Othman I; Yiap BC; Ong CE
    Biopharm Drug Dispos; 2018 Apr; 39(4):205-217. PubMed ID: 29488228
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vitro inhibition of CYP2C9-mediated warfarin 7-hydroxylation by iguratimod: possible mechanism of iguratimod-warfarin interaction.
    Yamaori S; Takami K; Shiozawa A; Sakuyama K; Matsuzawa N; Ohmori S
    Biol Pharm Bull; 2015; 38(3):441-7. PubMed ID: 25757926
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Relative contributions of CYP2C9 and 2C19 to phenytoin 4-hydroxylation in vitro: inhibition by sulfaphenazole, omeprazole, and ticlopidine.
    Giancarlo GM; Venkatakrishnan K; Granda BW; von Moltke LL; Greenblatt DJ
    Eur J Clin Pharmacol; 2001 Apr; 57(1):31-6. PubMed ID: 11372587
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Time course of the drug-drug interaction of acenocoumarol-miconazole.
    Lozano R; Frutos A
    Int J Clin Pharmacol Ther; 2018 Jan; 56(1):28-30. PubMed ID: 29162215
    [No Abstract]   [Full Text] [Related]  

  • 14. Inhibitory effects of calf thymus DNA on metabolism activity of CYP450 enzyme in human liver microsomes.
    Yang S; Qiu Z; Zhang Q; Chen J; Chen X
    Drug Metab Pharmacokinet; 2014; 29(6):475-81. PubMed ID: 25030415
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chloramphenicol is a potent inhibitor of cytochrome P450 isoforms CYP2C19 and CYP3A4 in human liver microsomes.
    Park JY; Kim KA; Kim SL
    Antimicrob Agents Chemother; 2003 Nov; 47(11):3464-9. PubMed ID: 14576103
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mechanisms of the stereoselective interaction between miconazole and racemic warfarin in human subjects.
    O'Reilly RA; Goulart DA; Kunze KL; Neal J; Gibaldi M; Eddy AC; Trager WF
    Clin Pharmacol Ther; 1992 Jun; 51(6):656-67. PubMed ID: 1611805
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Angiotensin II Receptor Blockers Inhibit the Generation of Epoxyeicosatrienoic Acid from Arachidonic Acid in Recombinant CYP2C9, CYP2J2 and Human Liver Microsomes.
    Senda A; Mukai Y; Hayakawa T; Kato Y; Eliasson E; Rane A; Toda T; Inotsume N
    Basic Clin Pharmacol Toxicol; 2017 Oct; 121(4):239-245. PubMed ID: 28374982
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prediction of in vivo drug-drug interactions from in vitro data : factors affecting prototypic drug-drug interactions involving CYP2C9, CYP2D6 and CYP3A4.
    Brown HS; Galetin A; Hallifax D; Houston JB
    Clin Pharmacokinet; 2006; 45(10):1035-50. PubMed ID: 16984215
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Relationship between phenytoin and tolbutamide hydroxylations in human liver microsomes.
    Doecke CJ; Veronese ME; Pond SM; Miners JO; Birkett DJ; Sansom LN; McManus ME
    Br J Clin Pharmacol; 1991 Feb; 31(2):125-30. PubMed ID: 2049228
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro evaluation of valproic acid as an inhibitor of human cytochrome P450 isoforms: preferential inhibition of cytochrome P450 2C9 (CYP2C9).
    Wen X; Wang JS; Kivistö KT; Neuvonen PJ; Backman JT
    Br J Clin Pharmacol; 2001 Nov; 52(5):547-53. PubMed ID: 11736863
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.